{
    "Case ID": "040648",
    "Crime_Name": [
        "Dispute over Costs Award"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Costs dispute"
    ],
    "Legal_Issue": [
        "Reasonableness of costs award, particularly expert disbursements"
    ],
    "Governing_Law": [
        "Federal Courts Rules"
    ],
    "Procedural_Stage": [
        "Post-trial costs assessment review"
    ],
    "Evidence_Assessment": [
        "Assessment of expert fee claims, photocopy expenses, and time records"
    ],
    "Decision_Outcome": [
        "Costs award reduced by $206,411.00; partial allowance of review"
    ],
    "Burden_of_Proof": [
        "On the party challenging the assessment (Merck)"
    ],
    "Credibility_Factor": [
        "Assessment officer's evaluation of reasonableness of claimed expenses"
    ],
    "Legal_Rule": [
        "Rule 414 of the Federal Courts Rules"
    ],
    "Standard_of_Review": [
        "Error in principle or unreasonableness"
    ],
    "Procedural_Issue": [
        "Request for judicial review of assessment officer's decision"
    ],
    "Grounds_for_Claim": [
        "Excessive and unsupported expert fees, particularly Dr. Langer's charges"
    ],
    "Outcome_on_Merits": [
        "Partial success for Merck; majority of costs award upheld"
    ],
    "Decision_Maker": [
        "Justice Gibson"
    ],
    "Judicial_Review_Outcome": [
        "Allowed in part"
    ],
    "Review_Standard": [
        "Error in principle or resulting unreasonableness"
    ],
    "Procedural_Fairness_Assessment": [
        "Assessment officer followed proper procedures; minor correction required"
    ],
    "Key_Evidence_Considered": [
        "Expert fee statements, number of experts used, itemized disbursements"
    ],
    "Legal_Framework": [
        "Federal Courts Rules, Rule 414"
    ],
    "Applicant_Challenge": [
        "Merck challenged Apotex's costs award as unreasonable"
    ],
    "Court_Result": [
        "Reduction in recoverable costs, otherwise affirmed"
    ],
    "Legal_Rule_Source": [
        "Federal Courts Rules"
    ],
    "Standard_of_Proof": [
        "Preponderance of evidence / reasonableness standard"
    ],
    "Defendant_Response": [
        "Apotex defended the assessed costs as reasonable and justified"
    ],
    "Evidence_Type": [
        "Financial records, expert invoices, assessment officer's report"
    ],
    "Remedy_Requested": [
        "Reduction of Apotex's costs award"
    ],
    "Outcome": [
        "Costs reduced by $206,411.00"
    ],
    "Decision_Authority": [
        "Federal Court judge under Rule 414"
    ],
    "Remedy_Sought": [
        "Adjustment of costs award"
    ],
    "Resolution_Mechanism": [
        "Judicial review of assessment officer's decision"
    ],
    "Legal_Provision": [
        "Rule 414"
    ],
    "Authority": [
        "Federal Court of Canada"
    ],
    "Claimant_Status": [
        "Merck as moving party"
    ],
    "Legal_Provision_Cited": [
        "Rule 414 of the Federal Courts Rules"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Allegation of excessive and unjustified expert disbursements"
    ],
    "Applicable_Process": [
        "Review process under Rule 414"
    ],
    "Outcome_of_Review": [
        "Partially allowed"
    ],
    "Pending_Relief_or_Application": [
        "Motion to review costs award"
    ],
    "Jurisdiction": [
        "Federal Court"
    ],
    "Governing_Rule": [
        "Rule 414 of the Federal Courts Rules"
    ]
}